FREE Account Opening + No Clearing Fees
Loading...

SMS Pharmaceuticals IPO vs Transwarranty IPO

Comparision between SMS Pharmaceuticals IPO and Transwarranty IPO.

IPO Details

SMS Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Transwarranty IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  SMS Pharmaceuticals IPO Transwarranty IPO
Logo SMS Pharmaceuticals IPO Logo Transwarranty IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE, NSE BSE, NSE
Lead Managers Uti Securities Ltd Idbi Capital Market Services Limited
Registrar Aarthi Consultants Pvt Ltd. Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of SMS Pharmaceuticals IPO is up to ₹97.93 Cr whereas the issue size of the Transwarranty IPO is up to ₹31.20 Cr. The final issue price of SMS Pharmaceuticals IPO is ₹380.00 per share and of Transwarranty IPO is ₹52.00 per share.

  SMS Pharmaceuticals IPO Transwarranty IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹360.00 per share ₹48.00 per share
Issue Price (Upper) ₹380.00 per share ₹55.00 per share
Issue Price (Final) ₹380.00 per share ₹52.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 15 shares 120 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 25,77,000 shares 60,00,000 shares
Issue Size Total (Amount) up to ₹97.93 Cr up to ₹31.20 Cr

IPO Timetable

SMS Pharmaceuticals IPO opens on Feb 05, 2007, while Transwarranty IPO opens on Jan 23, 2007. The closing date of SMS Pharmaceuticals IPO and Transwarranty IPO is Feb 08, 2007, and Feb 02, 2007, respectively.

  SMS Pharmaceuticals IPO Transwarranty IPO
Anchor Bid Date
Issue Open Feb 05, 2007 Jan 23, 2007
Issue Close Feb 08, 2007 Feb 02, 2007
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

SMS Pharmaceuticals IPO P/E ratio is , as compared to Transwarranty IPO P/E ratio of .

  SMS Pharmaceuticals IPO Transwarranty IPO
Financial
Promoter Shareholding (Pre-Issue) 72.31% 98.16%
Promoter Shareholding (Post-Issue) 53.68% 56.09%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 17.41%% 23.86%%

Shares Offered

In the SMS Pharmaceuticals IPO retail investors (RII) are offered while in Transwarranty IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in SMS Pharmaceuticals IPO and in Transwarranty IPO.

  SMS Pharmaceuticals IPO Transwarranty IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

SMS Pharmaceuticals IPO subscribed 2.64x in total, whereas Transwarranty IPO subscribed 1.59x.

  SMS Pharmaceuticals IPO Transwarranty IPO
QIB (times) 3.47x 1.03x
NII (times) 0.28x 1.87x
Big NII (times)
Small NII (times)
RII (times) 2.47x 2.34x
Employee (times) 0.24x
Other (times)
Total (times) 2.64x 1.59x

Comments

Add a public comment...